These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16463407)

  • 1. Glucocorticoid use, other associated factors, and the risk of tuberculosis.
    Jick SS; Lieberman ES; Rahman MU; Choi HK
    Arthritis Rheum; 2006 Feb; 55(1):19-26. PubMed ID: 16463407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment.
    Sugiyama T; Sugimoto T; Suzuki S; Sato Y; Tanaka T; Tatsuno I
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):616-20. PubMed ID: 25997545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
    Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
    PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and the risk of incident diabetes mellitus: a population-based study.
    Brauchli YB; Jick SS; Meier CR
    Br J Dermatol; 2008 Dec; 159(6):1331-7. PubMed ID: 18782318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying risks: the case between glucocorticoids and tuberculosis.
    Carmona L
    Arthritis Rheum; 2006 Feb; 55(1):1-2. PubMed ID: 16463392
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population.
    Kim HA; Yoo CD; Baek HJ; Lee EB; Ahn C; Han JS; Kim S; Lee JS; Choe KW; Song YW
    Clin Exp Rheumatol; 1998; 16(1):9-13. PubMed ID: 9543555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study.
    Hernández-Cruz B; Ponce-de-León-Rosales S; Sifuentes-Osornio J; Ponce-de-León-Garduño A; Díaz-Jouanen E
    Clin Exp Rheumatol; 1999; 17(1):81-7. PubMed ID: 10084037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.
    Souverein PC; Berard A; Van Staa TP; Cooper C; Egberts AC; Leufkens HG; Walker BR
    Heart; 2004 Aug; 90(8):859-65. PubMed ID: 15253953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoking and pulmonary tuberculosis: a case-control study.
    Dhamgaye TM
    J Indian Med Assoc; 2008 Apr; 106(4):216-9. PubMed ID: 18828338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of risk factors for development of active pulmonary tuberculosis in northern part of Ethiopia: a matched case control study.
    Berhe G; Enquselassie F; Aseffa A
    Ethiop Med J; 2013 Oct; 51(4):227-37. PubMed ID: 24696973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.
    Christiansen CF; Christensen S; Mehnert F; Cummings SR; Chapurlat RD; Sørensen HT
    Arch Intern Med; 2009 Oct; 169(18):1677-83. PubMed ID: 19822824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea.
    Lee SJ; Kim SW; Kong KA; Ryu YJ; Lee JH; Chang JH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():497-506. PubMed ID: 25784796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids and the increased risk of pulmonary tuberculosis: a population-based case-control study.
    Chung WS; Chen YF; Hsu JC; Yang WT; Chen SC; Chiang JY
    Int J Clin Pract; 2014 Oct; 68(10):1193-9. PubMed ID: 24838040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
    Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
    JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease.
    Hsing SC; Weng SF; Cheng KC; Shieh JM; Chen CH; Chiang SR; Wang JJ
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):928-33. PubMed ID: 23743312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for psoriasis in the general population.
    Huerta C; Rivero E; Rodríguez LA
    Arch Dermatol; 2007 Dec; 143(12):1559-65. PubMed ID: 18087008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the development of glucocorticoid-induced diabetes mellitus.
    Katsuyama T; Sada KE; Namba S; Watanabe H; Katsuyama E; Yamanari T; Wada J; Makino H
    Diabetes Res Clin Pract; 2015 May; 108(2):273-9. PubMed ID: 25765669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of incident active tuberculosis and use of corticosteroids.
    Lai CC; Lee MT; Lee SH; Lee SH; Chang SS; Lee CC
    Int J Tuberc Lung Dis; 2015 Aug; 19(8):936-42. PubMed ID: 26162360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking and its relation to pulmonary tuberculosis in adults.
    Ariyothai N; Podhipak A; Akarasewi P; Tornee S; Smithtikarn S; Thongprathum P
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):219-27. PubMed ID: 15272772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.